Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
An experimental and theoretical approach to the analysis of pharmaceutical binary systems.

Journal of pharmaceutical and biomedical analysis

Giordano F, Bettinetti GP.
PMID: 16867367
J Pharm Biomed Anal. 1988;6(6):951-5. doi: 10.1016/0731-7085(88)80115-8.

No abstract available.

Cite
Giordano F, Bettinetti GP. An experimental and theoretical approach to the analysis of pharmaceutical binary systems. J Pharm Biomed Anal. 1988;6(6):951-5doi: 10.1016/0731-7085(88)80115-8.
Giordano, F., & Bettinetti, G. P. (1988). An experimental and theoretical approach to the analysis of pharmaceutical binary systems. Journal of pharmaceutical and biomedical analysis, 6(6), 951-5. https://doi.org/10.1016/0731-7085(88)80115-8
Giordano, F, and Bettinetti, G P. "An experimental and theoretical approach to the analysis of pharmaceutical binary systems." Journal of pharmaceutical and biomedical analysis vol. 6,6 (1988): 951-5. doi: https://doi.org/10.1016/0731-7085(88)80115-8
Giordano F, Bettinetti GP. An experimental and theoretical approach to the analysis of pharmaceutical binary systems. J Pharm Biomed Anal. 1988;6(6):951-5. doi: 10.1016/0731-7085(88)80115-8. PMID: 16867367.
Copy Download .nbib Format: NLM
Cutaneous adverse reactions associated with antiseizure medication: clinical characteristics and implications in epilepsy treatment.

Epileptic disorders : international epilepsy journal with videotape

Tensini TS, Von Glehn CQC, Bettinotti MP, Iglehart B, de Paola L, Lohr A, Rodrigues M, Tensini FS, Braatz VL, Silvado CES.
PMID: 34080983
Epileptic Disord. 2021 Jun 01;23(3):466-475. doi: 10.1684/epd.2021.1288.

OBJECTIVE: To describe the clinical characteristics of cutaneous adverse reactions and cross-sensitivity induced by antiseizure medications and compare the pattern of use of antiseizure medications in patients with epilepsy according to skin rash history.METHODS: We analysed patients with a...

Cite
Tensini TS, Von Glehn CQC, Bettinotti MP, et al. Cutaneous adverse reactions associated with antiseizure medication: clinical characteristics and implications in epilepsy treatment. Epileptic Disord. 2021;23(3):466-475doi: 10.1684/epd.2021.1288.
Tensini, T. S., Von Glehn, C. Q. C., Bettinotti, M. P., Iglehart, B., de Paola, L., Lohr, A., Rodrigues, M., Tensini, F. S., Braatz, V. L., & Silvado, C. E. S. (2021). Cutaneous adverse reactions associated with antiseizure medication: clinical characteristics and implications in epilepsy treatment. Epileptic disorders : international epilepsy journal with videotape, 23(3), 466-475. https://doi.org/10.1684/epd.2021.1288
Tensini, Tallulah Spina, et al. "Cutaneous adverse reactions associated with antiseizure medication: clinical characteristics and implications in epilepsy treatment." Epileptic disorders : international epilepsy journal with videotape vol. 23,3 (2021): 466-475. doi: https://doi.org/10.1684/epd.2021.1288
Tensini TS, Von Glehn CQC, Bettinotti MP, Iglehart B, de Paola L, Lohr A, Rodrigues M, Tensini FS, Braatz VL, Silvado CES. Cutaneous adverse reactions associated with antiseizure medication: clinical characteristics and implications in epilepsy treatment. Epileptic Disord. 2021 Jun 01;23(3):466-475. doi: 10.1684/epd.2021.1288. PMID: 34080983.
Copy Download .nbib Format: NLM
Fused 3-Hydroxy-3-trifluoromethylpyrazoles Inhibit Mutant Huntingtin Toxicity.

ACS medicinal chemistry letters

La Rosa S, Benicchi T, Bettinetti L, Ceccarelli I, Diodato E, Federico C, Fiengo P, Franceschini D, Gokce O, Heitz F, Lazzeroni G, Luthi-Carter R, Magnoni L, Miragliotta V, Scali C, Valacchi M.
PMID: 24900595
ACS Med Chem Lett. 2013 Aug 08;4(10):979-84. doi: 10.1021/ml400251g. eCollection 2013 Oct 10.

Here, we describe the selection and optimization of a chemical series active in both a full-length and a fragment-based Huntington's disease (HD) assay. Twenty-four thousand small molecules were screened in a phenotypic HD assay, identifying a series of compounds...

Cite
La Rosa S, Benicchi T, Bettinetti L, et al. Fused 3-Hydroxy-3-trifluoromethylpyrazoles Inhibit Mutant Huntingtin Toxicity. ACS Med Chem Lett. 2013;4(10):979-84doi: 10.1021/ml400251g.
La Rosa, S., Benicchi, T., Bettinetti, L., Ceccarelli, I., Diodato, E., Federico, C., Fiengo, P., Franceschini, D., Gokce, O., Heitz, F., Lazzeroni, G., Luthi-Carter, R., Magnoni, L., Miragliotta, V., Scali, C., & Valacchi, M. (2013). Fused 3-Hydroxy-3-trifluoromethylpyrazoles Inhibit Mutant Huntingtin Toxicity. ACS medicinal chemistry letters, 4(10), 979-84. https://doi.org/10.1021/ml400251g
La Rosa, Salvatore, et al. "Fused 3-Hydroxy-3-trifluoromethylpyrazoles Inhibit Mutant Huntingtin Toxicity." ACS medicinal chemistry letters vol. 4,10 (2013): 979-84. doi: https://doi.org/10.1021/ml400251g
La Rosa S, Benicchi T, Bettinetti L, Ceccarelli I, Diodato E, Federico C, Fiengo P, Franceschini D, Gokce O, Heitz F, Lazzeroni G, Luthi-Carter R, Magnoni L, Miragliotta V, Scali C, Valacchi M. Fused 3-Hydroxy-3-trifluoromethylpyrazoles Inhibit Mutant Huntingtin Toxicity. ACS Med Chem Lett. 2013 Aug 08;4(10):979-84. doi: 10.1021/ml400251g. eCollection 2013 Oct 10. PMID: 24900595; PMCID: PMC4027250.
Copy Download .nbib Format: NLM
CD8+ T cell responses in convalescent COVID-19 individuals target epitopes from the entire SARS-CoV-2 proteome and show kinetics of early differentiation.

bioRxiv : the preprint server for biology

Kared H, Redd AD, Bloch EM, Bonny TS, Sumatoh H, Kairi F, Carbajo D, Abel B, Newell EW, Bettinotti MP, Benner SE, Patel EU, Littlefield K, Laeyendecker O, Shoham S, Sullivan D, Casadevall A, Pekosz A, Nardin A, Fehlings M, Tobian AA, Quinn TC.
PMID: 33052343
bioRxiv. 2020 Oct 08; doi: 10.1101/2020.10.08.330688.

Characterization of the T cell response in individuals who recover from SARS-CoV-2 infection is critical to understanding its contribution to protective immunity. A multiplexed peptide-MHC tetramer approach was used to screen 408 SARS-CoV-2 candidate epitopes for CD8+ T cell...

Cite
Kared H, Redd AD, Bloch EM, et al. CD8+ T cell responses in convalescent COVID-19 individuals target epitopes from the entire SARS-CoV-2 proteome and show kinetics of early differentiation. bioRxiv. 2020;doi: 10.1101/2020.10.08.330688.
Kared, H., Redd, A. D., Bloch, E. M., Bonny, T. S., Sumatoh, H., Kairi, F., Carbajo, D., Abel, B., Newell, E. W., Bettinotti, M. P., Benner, S. E., Patel, E. U., Littlefield, K., Laeyendecker, O., Shoham, S., Sullivan, D., Casadevall, A., Pekosz, A., Nardin, A., Fehlings, M., Tobian, A. A., & Quinn, T. C. (2020). CD8+ T cell responses in convalescent COVID-19 individuals target epitopes from the entire SARS-CoV-2 proteome and show kinetics of early differentiation. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2020.10.08.330688
Kared, Hassen, et al. "CD8+ T cell responses in convalescent COVID-19 individuals target epitopes from the entire SARS-CoV-2 proteome and show kinetics of early differentiation." bioRxiv : the preprint server for biology vol. (2020). doi: https://doi.org/10.1101/2020.10.08.330688
Kared H, Redd AD, Bloch EM, Bonny TS, Sumatoh H, Kairi F, Carbajo D, Abel B, Newell EW, Bettinotti MP, Benner SE, Patel EU, Littlefield K, Laeyendecker O, Shoham S, Sullivan D, Casadevall A, Pekosz A, Nardin A, Fehlings M, Tobian AA, Quinn TC. CD8+ T cell responses in convalescent COVID-19 individuals target epitopes from the entire SARS-CoV-2 proteome and show kinetics of early differentiation. bioRxiv. 2020 Oct 08; doi: 10.1101/2020.10.08.330688. PMID: 33052343; PMCID: PMC7553170.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries